tiprankstipranks
Trending News
More News >
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market

Zevra Therapeutics (ZVRA) Technical Analysis

Compare
897 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Zevra Therapeutics’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Zevra Therapeutics is a Buy.
Zevra Therapeutics’s (ZVRA) 20-Day exponential moving average is 9.08, while Zevra Therapeutics’s (ZVRA) share price is $9.74, making it a Buy.
Zevra Therapeutics’s (ZVRA) 50-Day exponential moving average is 8.66, while Zevra Therapeutics’s (ZVRA) share price is $9.74, making it a Buy.

Zevra Therapeutics (ZVRA) Pivot Points

Jul 06, 2025, 01:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.44
8.72
9.07
9.35
9.69
9.97
10.32
Fibonacci
8.72
8.96
9.11
9.35
9.58
9.73
9.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Jul 06, 2025, 01:04 PM
Period
Simple
Exponential
MA5
9.18Buy
9.34Buy
MA10
9.17Buy
9.22Buy
MA20
9.16Buy
9.08Buy
MA50
8.51Buy
8.66Buy
MA100
8.06Buy
8.33Buy
MA200
8.19Buy
8.10Buy
Zevra Therapeutics’s (ZVRA) 10-Day exponential moving average is 9.22, while Zevra Therapeutics’s (ZVRA) share price is $9.74, making it a Buy.
Zevra Therapeutics’s (ZVRA) 100-Day exponential moving average is 8.33, while Zevra Therapeutics’s (ZVRA) share price is $9.74, making it a Buy.
Zevra Therapeutics’s (ZVRA) stock price is $9.74 and Zevra Therapeutics’s (ZVRA) 50-day simple moving average is 8.51, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) stock price is $9.74 and Zevra Therapeutics’s (ZVRA) 100-day simple moving average is 8.06, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) stock price is $9.74 and Zevra Therapeutics’s (ZVRA) 200-day simple moving average is 8.19, creating a Buy signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Jul 06, 2025, 01:04 PM
Name
Value
Implied Action
RSI (14)
65.75
Neutral
STOCH (9,6)
67.65
Neutral
STOCHRSI (14)
65.00
Neutral
MACD (12,26)
0.21
Buy
ADX (14)
23.32
Neutral
Williams %R
-20.00
Sell
CCI (14)
213.17
Sell
ATR (14)
0.39
-
Ultimate Oscillator
57.05
Neutral
ROC
3.95
Buy
Zevra Therapeutics’s (ZVRA) Relative Strength Index (RSI) is 65.75, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Trend Strength Indicator (ADX) is 23.32, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Commodity Channel Index (CCI) is 213.17, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) Price Rate of Change (ROC) is 3.95, creating a Buy signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Strong Buy.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 65.75, which suggests ZVRA is a Neutral.
      What is ZVRA’s MACD?
      ZVRA’s MACD is 0.21, which suggests ZVRA is a Buy.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 9.18, which suggests ZVRA is a Buy.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 9.16, which suggests ZVRA is a Buy.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 8.51, which suggests ZVRA is a Buy.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 8.19, which suggests ZVRA is a Buy.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -20.00, which suggests ZVRA is a Sell.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is 213.17, which suggests ZVRA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis